Assessment of change of dose permitting use in children aged between 2 and 16.
-
Clinical Benefit
Substantial
The clinical benefit provided by DUROGESIC in children is substantial.
Clinical Added Value
Comments without ASMR value
DUROGESIC has previously been recognised by the Transparency Committee as providing actual benefit in adults, and it provides the same benefit for children over 2.
Listen
